» Articles » PMID: 38823001

Mechanistic Evaluation of MiRNAs and Their Targeted Genes in the Pathogenesis and Therapeutics of Parkinson's Disease

Overview
Journal Mol Neurobiol
Date 2024 Jun 1
PMID 38823001
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNA (miRNA) are usually 18-25 nucleotides long non-coding RNA targeting post-transcriptional regulation of genes involved in various biological processes. The function of miRNA is essential for maintaining a homeostatic cellular condition, regulating autophagy, cellular motility, and inflammation. Dysregulation of miRNA is responsible for multiple disorders, including neurodegeneration, which has emerged as a severe problem in recent times and has verified itself as a life-threatening condition that can be understood by the continuous destruction of neurons affecting various cognitive and motor functions. Parkinson's disease (PD) is the second most common, permanently debilitating neurodegenerative disorder after Alzheimer's, mainly characterized by uncontrolled tremor, stiffness, bradykinesia or akinesia (slowness in movement), and post-traumatic stress disorder. PD is mainly caused by the demolition of the primary dopamine neurotransmitter secretory cells and dopaminergic or dopamine secretory neurons in the substantia nigra pars compacta of the midbrain, which are majorly responsible for motor functions. In this study, a systematic evaluation of research articles from year 2017 to 2022 was performed on multiple search engines, and lists of miRNA being dysregulated in PD in different body components were generated. This study highlighted miR-7, miR-124, miR-29 family, and miR-425, showing altered expression levels during PD's progression, further regulating the expression of multiple genes responsible for PD.

Citing Articles

[High expression of miR-124 improves cognitive function of sleep-deprived rats by modulating the PI3K/AKT signaling pathway].

Pei Y, Liu H, Xin Y, Liu B Nan Fang Yi Ke Da Xue Xue Bao. 2025; 45(2):340-346.

PMID: 40031978 PMC: 11875864. DOI: 10.12122/j.issn.1673-4254.2025.02.15.


Leveraging plant-derived nanovesicles for advanced nucleic acid-based gene therapy.

Chai M, Gao B, Wang S, Zhang L, Pei X, Yue B Theranostics. 2025; 15(1):324-339.

PMID: 39744221 PMC: 11667239. DOI: 10.7150/thno.104507.

References
1.
Lee R, Feinbaum R, Ambros V . The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993; 75(5):843-54. DOI: 10.1016/0092-8674(93)90529-y. View

2.
Cho H, Liu G, Jin S, Parisiadou L, Xie C, Yu J . MicroRNA-205 regulates the expression of Parkinson's disease-related leucine-rich repeat kinase 2 protein. Hum Mol Genet. 2012; 22(3):608-20. PMC: 3542867. DOI: 10.1093/hmg/dds470. View

3.
Marques T, Kuiperij H, Bruinsma I, van Rumund A, Aerts M, Esselink R . MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson's Disease and Multiple System Atrophy. Mol Neurobiol. 2016; 54(10):7736-7745. PMC: 5684261. DOI: 10.1007/s12035-016-0253-0. View

4.
Li M, Marin-Muller C, Bharadwaj U, Chow K, Yao Q, Chen C . MicroRNAs: control and loss of control in human physiology and disease. World J Surg. 2008; 33(4):667-84. PMC: 2933043. DOI: 10.1007/s00268-008-9836-x. View

5.
Gennarino V, Sardiello M, Mutarelli M, Dharmalingam G, Maselli V, Lago G . HOCTAR database: a unique resource for microRNA target prediction. Gene. 2011; 480(1-2):51-8. PMC: 3113163. DOI: 10.1016/j.gene.2011.03.005. View